STARLA HORTON: Open Payments
NPI 1518412691 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 23 payments from 12 companies in 2025. Trend: 2023 $374 · 2024 $1,472 · 2025 $634
| Company | Payments | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. | 2 | $107 |
| Medtronic, Inc. | 4 | $102 |
| Artivion, Inc. | 2 | $73 |
| LeMaitre Vascular, Inc. | 3 | $61 |
| Abbott Laboratories | 2 | $50 |
| ABIOMED | 2 | $45 |
| Dilon Technologies, Inc. | 2 | $45 |
| Kerecis Limited | 2 | $40 |
| Boston Scientific Corporation | 1 | $37 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: EXCLUDER Conformable AAA Endoprosthesis with Active Control, COREVALVE EVOLUT R, AMDS-Ascyrus Medical, NAVITOR, HEMOBLAST BELLOWS, Kerecis SurgiClose, XENOSURE BIOLOGIC PATCH, ENROUTE Transcarotid Stent.
Industry payments across MS — which companies pay providers there.
